September 25, 2025

ImmuneWatch will be attending the World Vaccine Congress Europe in Amsterdam

Meet us at the upcoming World Vaccine Congress Europe in Amsterdam. Both our CEO, Sander Wuyts and our COO Tom Bosschaerts will be joining the R&D and strategic partnering meeting for the global vaccine industry.

Book a meeting

Stay up to date

Subscribe to our newsletter to receive useful tips and information.

Thank you! Your submission has been received!
Oups ! Un problème s'est produit lors de l'envoi du formulaire.

Recommended articles

January 14, 2025

New academic paper: tcrBLOSUM for advancing TCR Repertoire analysis

ImmuneWatch cofounders Pieter Meysman and Kris Laukens have introduced tcrBLOSUM, a specialised amino acid substitution matrix designed to enhance TCR repertoire analysis.

Read more
October 23, 2024

ImmuneWatch DETECT Model Leads the Field in IMMREP23 TCR-epitope Prediction Challenge

ImmuneWatch is proud to announce that its proprietary TCR-epitope prediction tool, ImmuneWatch DETECT, has achieved top performance in the IMMREP23 benchmark competition.

Read more
ImmuneWatch BV BE0774.472.942
Lange Gasthuisstraat 29-31, 2000, Antwerp, Belgium
Business@immunewatch.com
Solutions
ImmuneWatch DETECT
ImmuneWatch DESIGN
Company
Home
About us
News
Use cases
Careers
Contact
Connect
Linkedin
Bluesky
YouTube
Spotify
Subscribe to our newsletter
Thank you! Your submission has been received!
A problem occurred, please send us a message instead
By registering, you agree to our privacy policy and consent to receive updates from our company.
© 2025 ImmuneWatch
Privacy and Cookie Policy
SKROL